research use only
Cat.No.S8595
|
In vitro |
Water : 100 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 3741.1 | Formula | C164H251N57O45 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1423821-88-8 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CCC(C)C(NNC(CC1=C[NH]C2=C1C=CC=C2)C(=O)NC(CC3=CN=C[NH]3)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C(C)O)C(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC5=CC=CC=C5)C(=O)C(=O)C(NC(=O | ||
| Targets/IC50/Ki |
Beclin 1
|
|---|---|
| In vitro |
Tat-beclin 1 (Tat-BECN1) is a cell-permeable peptide that induces autophagy. Treatment with this compound, but not Tat-scrambled, results in a dose-dependent decrease in amounts of p62, a selective autophagy substrate, and a dose-dependent conversion of the non-lipidated form of LC3, LC3-I, to the lipidated, autophagosome-associated form of LC3, LC3-II, in multiple cell lines and primary murine embryonic fibroblasts (MEFs). It markedly inhibits HIV-1 replication in primary human monocyte-derived macrophages.
|
| In vivo |
Tat-beclin 1 (Tat-BECN1) can induce autophagy in peripheral tissues in adult mice as well as in the central nervous system of neonatal mice. Daily treatment with this compound is well-tolerated in both neonatal and adult mice, and it improves the clinical outcome of mice with CNS WNV(West Nile virus) infection.
|
References |
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | LC3A-II / LC3B-II POU5F1 / NANOG / SOX2 TUBB3 / CSN2 |
|
27929731 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.